Longitudinal evaluation of oral mucositis in hematopoietic stem cell transplantation: a pilot study

Authors

  • Carolina Eurich Mazur Federal University of Parana.
  • Camila Pinheiro Furquim Federal University of Parana.
  • Samir Kanaan Nabhan Federal University of Parana.
  • Geisla Mary Silva Soares Federal University of Parana.
  • José Miguel Amenábar Federal University of Parana.
  • Cassius Carvalho Torres-Pereira Federal University of Parana.

DOI:

https://doi.org/10.59334/ROV.v1i30.132

Keywords:

Oral mucositis, Stem Cell Transplantation, Haematological neoplasms

Abstract

Aim: To describe the oral mucositis (OM)` incidence and score, and related morbidities in individuals submitted to Hematopoietic Stem Cell Transplantation (HSCT) throughout the immunosuppression period of time

Methods: Subjects with onco / hematological diseases, older than 14 years, submitted to allogeneic HSCT were daily evaluated by the presence and classification of OM, pain level, dysphagia, dysgeusia and xerostomia. The examination started two days before the infusion of hematopoietic stem cells and ended twenty days later. The OM was classified according to the WHO scale and visual analog scale (VAS) was used to measure pain level

Results: Twenty-three individuals were recruted, 83% with malignant diseases and 91% had OM. The median of maximum OM degree was 3 and the maximum pain level was 9. There was a median of 11 days of opioid medication use. The subjects who had the highest mean number of days with mouth pain reached the maximum degree of OM and higher number of days and opiod use.

Conclusion: There was a high incidence and high scores of OM, loss of body mass and pain in this sample.

Downloads

Download data is not yet available.

References

ABESO, 2016. Diretrizes Brasileiras de Obesidade [WWW Document]. URL http://www.abeso.org.br/uploads/downloads/92/57fccc403e5da.pdf (accessed 12.11.17).

Ahmed, A.A.M., Selim, M.A.A., El-sayed, N.M., 2017. α -Lipoic acid ameliorates oral mucositis and oxidative stress induced by methotrexate in rats . Histological and immunohistochemical study. Life Sci. 171, 51–59. https://doi.org/10.1016/j.lfs.2017.01.001

Armitage, J.O., 1994. Bone Marrow Transplantation. N. Engl. J. Med. 330, 827–838. https://doi.org/10.1056/NEJM199403243301206

Bacigalupo, A., Ballen, K., Rizzo, D., Giralt, S., Lazarus, H., Ho, V., Apperley, J., Slavin, S., Pasquini, M., Sandmaier, B.M., Barrett, J., Blaise, D., Lowski, R., Horowitz, M., 2009. Defining the Intensity of Conditioning Regimens : Working Definitions. Biol. Blood Marrow Transplant. 15, 1628–1633. https://doi.org/10.1016/j.bbmt.2009.07.004

Bardellini, E., Schumacher, F., Conti, G., Porta, F., Campus, G., Majorana, A., 2013. Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: A retrospective study. Pediatr. Transplant. 17, 492–497. https://doi.org/10.1111/petr.12094

Boer, C.C., Correa, M.E.P., Miranda, E.C.M., Souza, C.A. De, 2009. Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant. 45, 705–711. https://doi.org/10.1038/bmt.2009.237

Chaudhry, H.M., Bruce, A.J., Wolf, R.C., Litzow, M.R., Hogan, W.J., Patnaik, M.S., Kremers, W.K., Phillips, G.L., Hashmi, S.K., 2016. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review. Biol. Blood Marrow Transplant. 22, 605–616. https://doi.org/10.1016/j.bbmt.2015.09.014

Cutler, C., Li, S., Kim, H.T., Laglenne, P., Szeto, K.C., Hoffmeister, L., Harrison, M.J., Ho, V., Alyea, E., Lee, S.J., Soiffer, R., Sonis, S., Antin, J.H., 2005. Mucositis after Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study of Methotrexate- and Non-Methotrexate-Containing Graft-versus-Host Disease Prophylaxis Regimens. Biol. Blood Marrow Transplant. 11, 383–388. https://doi.org/10.1016/j.bbmt.2005.02.006

Eslami, H., Pouralibaba, F., Falsafi, P., Bohluli, S., Najati, B., Negahdari, R., Ghanizadeh, M., 2016. Efficacy of Hypozalix spray and propolis mouthwash for prevention of chemotherapy-induced oral mucositis in leukemic patients: A double-blind randomized clinical trial. J. Dent. Res. Dent. Clin. Dent. Prospects 10, 226–233. https://doi.org/10.15171/joddd.2016.036

Haverman, T.M., Rademacher, W.M.H., Vokurka, S., Epstein, J.B., Huisman, C., Hazenberg, M.D., Soet, J.J. De, Lange, J. De, Rozema, F.R., 2014. Oral Complications in Hematopoietic Stem Cell Recipients : The Role of Inflammation 2014. Knoll, K., Anzengruber, F., Murer, C., Navarini, A.A., French, L.E., 2016. Mucocutaneous Ulcerations and Pancytopenia due to Methotrexate Overdose 287–293. https://doi.org/10.1159/000446692

Laaksonen, M., Ramseier, A.M., Rovó, A., Jensen, S.B., Raber-Durlacher, J.E., Zitzmann, N.U., Waltimo, T., 2011. Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation. J. Dent. Res. 90, 1177–82. https://doi.org/10.1177/0022034511414156

Lange, M.C., Teive, H.A.G., Troiano, A.R., Bitencourt, M., Funke, V.A.M., Setúbal, D.C., Zanis Neto, J., Medeiros, C.R., Werneck, L.C., Pasquini, R., Bonfim, C.M.S., 2006. Bone marrow transplantation in patients with storage diseases: a developing country experience. Arq. Neuropsiquiatr. 64, 1–4. https://doi.org/10.1590/S0004-282X2006000100001

Matsukawa, T., Hashimoto, D., Sugita, J., Nakazawa, S., 2016. Reduced - dose methotrexate in combination with tacrolimus was associated with rapid engraftment and recovery from oral mucositis without affecting the incidence of GVHD. Int. J. Hematol. 104, 117–124. https://doi.org/10.1007/s12185-016-1996-0

Peterson, D.E., Bensadoun, R.-J., Roila, F., ESMO Guidelines Working Group, 2011. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann. Oncol. 22, vi78-vi84. https://doi.org/10.1093/annonc/mdr391

Ramírez-amador, V., Anaya-saavedra, G., Crespo-solís, E., Camacho, E.I., González-ramírez, I., Ponce-de-león, S., 2010. Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy 639–646. https://doi.org/10.1007/s00520-009-0708-1

Ribeiro, E.M., Cavalli, I.J., Schmid, A.T., Cornélio, D.A., Tokutake, A.S., Sperandio-Roxo, V.M., Rodriguez, J.M., Pasquini, R., 1996. Cytogenetic analysis in human bone marrow transplantation. Cancer Genet. Cytogenet. 89, 21–6. https://doi.org/10.1016/0165-4608(95)00313-4

Ruiz-Argüelles, G.J., Abello-Polo, V., Arrais-Rodrígues, C., Bouzas, L.F., de Souza, C., Dufort, G., Gabus, R., Galindo-Becerra, L.S., Gómez-Almaguer, D., Hammerschlak, N., Jaime-Fagundo, J.C., Jaimovich, G., Karduss-Urueta, A.J., Labas-tida-Mercado, N., Nese, M., Pasquini, R., Seber, A., 2015. Publications of bone marrow transplants in Latin America. A report of the Latin American Group of Bone Marrow Transplantation. Bone Marrow Transplant. 50, 1130–1131. https://doi.org/10.1038/bmt.2015.107

Silva, L.C., Sacono, N.T., Freire, M. do C.M., Costa, L.R., Batista, A.C., Silva, G.B.L., 2015. The Impact of Low-Level Laser Therapy on Oral Mucositis and Quality of Life in Patients Undergoing Hematopoietic Stem Cell Transplantation Using the Oral Health Impact Profile and the Functional Assessment of Cancer Therapy-Bone Marrow Transplanta-tion Questionnaires. Photomed. Laser Surg. 33, 357–363. https://doi.org/10.1089/pho.2015.3911

Small, T.N., Young, J.W., Castro-malaspina, H., Prockop, S., Wilton, A., 2007. Intravenous Busulfan and Melphalan, Tacrolimus , and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic Malignancies 244, 235–244. https://doi.org/10.1016/j.bbmt.2006.10.005

Sonis, S.T., 2012. Oral Mucositis. Springer Healthcare Ltd., Tarporley. https://doi.org/10.1007/978-1-907673-46-7

Sonis, S.T., 2012. The Pathobiology of Oral Mucositis, in: Oral Mucositis. Springer Healthcare Ltd., Tarporley, pp. 7–13. https://doi.org/10.1007/978-1-907673-46-7_2

Thomaz, A.C., Silvério, C.I., Campos, D.J., Emilia, E., Kieuteka, M., Rabito, E.I., Araújo, V., Funke, M., Vilela, R.M., 2015. Pre-transplant arm muscle area : a simple measure to identify patients at risk 3385–3391. https://doi.org/10.1007/s00520-015-2850-2

Turner, B.E., Collin, M., Rice, A.M., 2010. Reduced intensity conditioning for hematopoietic stem cell transplantation : has it achieved all it set out to ? Cytotherapy 12, 440–454. https://doi.org/10.3109/14653241003709678

Vera-Llonch, M., Oster, G., Ford, C.M., Lu, J., Sonis, S., 2007. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer 15, 491–496. https://doi.org/10.1007/s00520-006-0176-9

WHO, 2017. WHO | World Health Organization - oral mucositis scale. WHO.

Wojciechowicz, J., Kostyra, M., Kozi, J., Hus, M., Tomaszewski, T., 2014. Acta Haematologica Polonica Oral mucositis in patients with leukaemia following high-dose chemotherapy and autologous haematopoietic stem cells transplantation 5, 6–11. https://doi.org/10.1016/j.achaem.2014.02.001

Published

2019-06-01

Issue

Section

Research Article

How to Cite

Longitudinal evaluation of oral mucositis in hematopoietic stem cell transplantation: a pilot study. (2019). Odontología Vital, 1(30), 31-38. https://doi.org/10.59334/ROV.v1i30.132

Similar Articles

1-10 of 200

You may also start an advanced similarity search for this article.